£90.98

Springer - Intellectual Property Rights in Pharmaceutical Test Data

Name: Springer - Intellectual Property Rights in Pharmaceutical Test Data
Brand: Springer
Price: 90.98 GBP
Availability: InStock

Law

It has never been this cheap. We have no record of a lower price.

£91 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 61 days • 61 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 61 days • 3 price levels

Days at Price

Current Price

Price Analysis

Most common price: £91 (33 days, 54.1%)

Price range: £91 - £107

Price levels: 3 different prices over 61 days

Description

Explore the complex landscape of pharmaceutical law with this academic study from Springer. This book examines the intellectual property protection of clinical test data submitted to governments, specifically focusing on test data exclusivity rights. It provides a detailed look at how these rights emerged in the early 1980s and how they have expanded through globalisation over the last forty years. Readers will gain a deep understanding of the impact these intellectual property protections have on global access to medicine. By applying the theory of regulatory globalisation, the text offers a unique explanation for the development and spread of these legal frameworks. This work is an essential resource for those studying the intersection of law, pharmaceutical regulation, and global health policy.

Key Features

Examines the history and evolution of clinical test data protection since the early 1980s.

Analyzes how test data exclusivity rights have globalised over the past four decades.

Investigates the direct impact of intellectual property rights on global access to medicine.

Provides original contributions to legal literature regarding the protection of submitted test data.

Uses the theory of regulatory globalisation to explain international legal developments.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 3031294351
Category: Books > Subjects > Business, Finance & Law > Law
Domain: Amazon UK
Release Date: 13 May 2023
Listed Since: 24 February 2023

Barcode

No barcode data available

Springer - Intellectual Property Rights in Pharmaceutical Test Data

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

Springer - Intellectual Property and Health Technologies

Intellectual Property and Health Technologies: Balancing Innovation and the Public's Health

Interpreting TRIPS: Globalisation of Intellectual Property Rights and Access to Medicines

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

World Scientific Strategic Marketing Specialty Pharmaceuticals Book

Mastering Strategic Marketing For Specialty Pharmaceuticals: A Hands-on Guide

Artificial Intelligence in Drug Development: Patenting and Regulatory Aspects (Frontiers of Artificial Intelligence, Ethics and Multidisciplinary Applications)

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Regional Cooperation, Intellectual Property Law and Access to Medicines: A Holistic Approach for Least Developed Countries (Routledge Research in Health Law)

A Biotech Manager's Handbook: A Practical Guide (Woodhead Publishing Series in Biomedicine)

Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health, and Pharmaceuticals (Law, Development and Globalization)

Personalized Medicine in Healthcare Systems: Legal, Medical and Economic Implications: 5 (Europeanization and Globalization, 5)

Guide to EU and UK Pharmaceutical Regulatory Law

Forschung wider Willen?: Rechtsprobleme biomedizinischer Forschung mit nichteinwilligungsfähigen Personen (MedR Schriftenreihe Medizinrecht)

Personalized Medicine in Healthcare Systems: Legal, Medical and Economic Implications: 5 (Europeanization and Globalization, 5)

Economics of the Pharmaceutical and Medical Device Industry: Supply Chain, Trade and Innovation (Routledge Studies in the Economics of Innovation)

Edward Elgar - Intellectual Property, Pharmaceuticals and Public Health

Pharmaceutical Test Data Exclusivity: A Multi-Jurisdictional Survey (AIPPI Law, 7)

The Law of Off-label Uses of Medicines: Regulation and Litigation in the EU, UK and USA

Oxford University Press - Balancing Wealth and Health Book

Antitrust in Pharmaceutical Markets & Geographical Rules of Origin (LIDC Contributions on Antitrust Law, Intellectual Property and Unfair Competition)

Die Patentfähigkeit von Arzneimitteln: Der gewerbliche Rechtsschutz für pharmazeutische, medizinische und biotechnologische Erfindungen: 14 ... Universitäten Heidelberg und Mannheim, 14)

Drug Control and International Law (Routledge Research in International Law)

Biotechnology, Patents and Human Rights in Europe: Innovations Concerning the Human Body